The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer
Authors:
- the Australasian Gastro-Intestinal Trials Group (AGITG) GAP investigatorsTIthe Australasian Gastro-Intestinal Trials Group (AGITG) GAP investigators
- Andrew P. BarbourABAndrew P. Barbour
- Nick O’rOurkeNONick O’rOurke
- Val J. GebskiVGVal J. Gebski
- 29 January 2020
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 27 (7) , 2506-2515
Abstract
While combination therapy with nab-paclitaxel/gemcitabine (nab-gem) is effective in pancreatic ductal adenocarcinoma (PDAC), its efficacy as perioperativeKeywords
Funding Information
- Specialised Therapeutics Australia
- National Health and Medical Research Council of Australia (APP1026563)
This publication has 47 references indexed in Scilit:
- Pancreatic Ductal AdenocarcinomaAnnals of Surgery, 2013
- Pancreatic Cancer Surgery in the New MillenniumAnnals of Surgery, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection PercentagesPLOS Medicine, 2010
- Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic HeadJournal of Clinical Oncology, 2008
- Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic HeadJournal of Clinical Oncology, 2008
- Prospective Phase II Trial of Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Resectable Adenocarcinoma of the Pancreatic HeadJournal of Clinical Oncology, 2008
- Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic AdenocarcinomaAnnals of Surgery, 2007
- A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with CisplatinAnnals of Surgical Oncology, 2007
- Pathological response following long‐course neoadjuvant chemoradiotherapy for locally advanced rectal cancerHistopathology, 2005